0
2022
Catheters Market

Catheters Market

by Product Type (Cardiovascular Catheters, Neurovascular Catheters, Urological Catheters, Intravenous Catheters, Specialty Catheters): Global Opportunity Analysis and Industry Forecast, 2021-2031

✷  Report Code: A00467
May 2022 | Pages: 314
Tables: 90
Charts: 53
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Catheters Market Research, 2031

The global catheters market was valued at $22.7 billion in 2021, and is projected to reach $49.5 billion by 2031, growing at a CAGR of 8.1% from 2022 to 2031.Catheterization is type of co-procedure performed along with varied medical procedures including, angioplasty, cardiac electrophysiology, and neurological surgery. It is a tube that is inserted into bladder, allowing urine to pass freely. There are various types of catheters, such as cardiovascular catheters, neurovascular catheters, urological catheters, and specialty catheters. Catheters are usually used for short time period, for instance,  for a number of weeks or months when continuous bladder drainage is needed, but occasionally they are required for long term use. Urinary catheters are used when people have difficulty is passing the urine naturally. It can also be used to empty the bladder before or after surgery.

The COVID-19 pandemic negatively impacted the global catheter market initially in 2020 due to global economic recession led by COVID-19. However, the market is anticipated to witness recovery in 2021, and show stable growth for catheter in the coming future.

Catheters Market, Catheters Market size, Catheters Market share, Catheters Market trends, Catheters Market growth, Catheters Market analysis, Catheters Market forecast, Catheters Market opportunity

Growth of the global catheters market is majorly driven by rise in prevalence of cardiovascular diseases along with the increase in demand for minimal invasive surgeries. In addition, significant increase in prevalence of chronic diseases associated with urinary bladder, kidney failures, and others are the major factors that drive the growth during catheters market forecast. In addition, surge in demand for minimal invasive surgeries among patients further fuels the catheters market growth. In addition, increase in incontinence problems owing to rise in geriatric population base across the globe, and increase in demand for sterile & disposable catheters contribute to the market growth.  Moreover, development of new catheters by large number of key players fuel the growth of catheters market size. Furthermore, rise in geriatric population and increase in number of patients suffering from bladder cancer fuel the growth of the catheters market. Furthermore, growth in demand for minimally invasive procedures, due to the recent technological innovations is expected to increase the demand for catheters. For instance, growth in demand for angioplasty over conventional surgeries, owing to its minimally invasive nature, attributes toward the market growth
Furthermore, increase in number of product approvals is expected to provide lucrative catheters market opportunity for the growth of the global catheters market during the forecast period. For instance, in March 2022, Cerus Endovascular has received the U.S food and drugs administration approval for its 027 micro-catheter, which contour neurovascular system. 
The COVID-19 outbreak is anticipated to have a short-term negative impact on the growth of the global catheters industry due to on-hold services, such as treatment, diagnostic, and surgical services, to prevent the spread of COVID-19 disease. According to the National Library of Medicine, Jordan imposed strict COVID-19-related lockdown. The strict lockdown was associated with drastic declines in volumes of cardiac catheterization procedures with gradual increase in volumes after partial lifting of the lockdown. However, catheters will be used more often in hospitals as the government and healthcare organizations work to improve medical treatment for COVID-19 patients. The patients who confirmed diagnosis of COVID-19 are being treated with catheters. For instance, in April 2020, Bactiguard introduced a new urinary catheter, BIP Foley TempSensor for continuous temperature monitoring. The company reported in pandemic that it has a urinary catheter combined with integrated temperature monitoring and infection control. Thus, such technological advancements help to drive the growth of the catheters market during the forecast period.
However, due to increase in number of entrants in the domestic market, the quality of catheter devices deteriorates as these manufacturers use cheap and substandard raw material to manufacture the product at low price, restricting  the market growth.


Catheter Market Segmentation

The catheters market is segmented on the basis of product type and region. By product type, the market is categorized into cardiovascular catheters, neurovascular catheters, urological catheters, and specialty catheters. Cardiovascular catheters segment is classified into electrophysiology catheters, percutaneous transluminal coronary angioplasty (PTCA) balloon catheters, intravascular ultrasound (IVUS catheters), percutaneous transluminal angioplasty (PTA) catheters, and others include guiding catheter, angiography catheter, and pulmonary artery catheters. In addition, urological catheter segment is fragmented into dialysis catheter and urinary catheter. Dialysis catheter segment is segmented into hemodialysis catheter and peritoneal catheter.  Urinary catheter segment is  sub segmented into and foley catheter, intermittent catheter, and external catheters.  Furthermore, intravenous catheter segment  is divided into central intravenous catheter and peripheral intravenous catheters. Peripheral intravenous catheters is fragmented into integrated catheters and short catheters. Moreover, specialty catheters segment is divided into wound/surgical drain, oximetry, thermodilution, and intrauterine Insemination(IUI) catheters
    
Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Segment Review
Depending on product type, the cardiovascular catheter segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing to rise in prevalence of cardiovascular diseases along with the increase in demand for minimal invasive surgeries. In addition, rise in usage to evaluate and confirm the presence of diseases related to heart such as valve disease, coronary artery disease, and diseases related to the aorta further drive the growth of cardiovascular catheter segment. However, the urological catheter segment is expected to witness considerable growth during the forecast period, owing to increase in usage of urological catheters, due to increase in prevalence of end-stage renal diseases, kidney problem, and urinary tract infection. 

Catheters Market

Region wise, North America garnered the major catheters market share in 2021, and is expected to continue to dominate during the forecast period, owing to increase in the product launches and the increase in number of regulatory approvals in the developed countries of North America positively impacting the market growth. However, Asia-Pacific is expected to register the highest CAGR of 11.9% from 2022 to 2031, owing to increase in demand for catheters due to rise in incidence of cardiovascular diseases and immunological & neurological diseases. 

Catheters Market

The key players that operate in the global catheters market include Abbott Laboratories, Becton Dickinson And Company, Boston Scientific Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Johnson & Johnson, Medtronic, Inc., Edwards Lifesciences Corporation, Cook Medical, and Stryker Corporation.
 

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the catheters market analysis from 2021 to 2031 to identify the prevailing catheters market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the catheters market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global catheters market trends, key players, market segments, application areas, and market growth strategies.

Catheters Market Report Highlights

Aspects Details
By Product Type
  • Cardiovascular Catheters
  • Neurovascular Catheters
  • Urological Catheters
  • Intravenous Catheters
  • Specialty Catheters
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players Becton, Dickinson and Company, Boston Scientific Corporation, Edwards Lifesciences Corporation, Cook Medical Inc., B. Braun Melsungen AG, Medtronic Plc, Johnson and Johnson, Stryker Corporation, Abbott Laboratories, Teleflex Incorporated
 
  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Top player positioning

    • 3.5.Market dynamics

      • 3.5.1.Drivers

      • 3.5.2.Restraints

      • 3.5.3.Opportunities

    • 3.6.COVID-19 Impact Analysis on the market

  • CHAPTER 4: CATHETERS MARKET, BY PRODUCT TYPE

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2 Cardiovascular Catheters

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market analysis by country

    • 4.3 Neurovascular Catheters

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market analysis by country

    • 4.4 Urological Catheters

      • 4.4.1 Key market trends, growth factors and opportunities

      • 4.4.2 Market size and forecast, by region

      • 4.4.3 Market analysis by country

    • 4.5 Intravenous Catheters

      • 4.5.1 Key market trends, growth factors and opportunities

      • 4.5.2 Market size and forecast, by region

      • 4.5.3 Market analysis by country

    • 4.6 Specialty Catheters

      • 4.6.1 Key market trends, growth factors and opportunities

      • 4.6.2 Market size and forecast, by region

      • 4.6.3 Market analysis by country

  • CHAPTER 5: CATHETERS MARKET, BY REGION

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2 North America

      • 5.2.1 Key trends and opportunities

      • 5.2.2 North America Market size and forecast, by Product Type

      • 5.2.3 North America Market size and forecast, by country

        • 5.2.3.1 U.S.
          • 5.2.3.1.1 Market size and forecast, by Product Type
        • 5.2.3.2 Canada
          • 5.2.3.2.1 Market size and forecast, by Product Type
        • 5.2.3.3 Mexico
          • 5.2.3.3.1 Market size and forecast, by Product Type
    • 5.3 Europe

      • 5.3.1 Key trends and opportunities

      • 5.3.2 Europe Market size and forecast, by Product Type

      • 5.3.3 Europe Market size and forecast, by country

        • 5.3.3.1 Germany
          • 5.3.3.1.1 Market size and forecast, by Product Type
        • 5.3.3.2 France
          • 5.3.3.2.1 Market size and forecast, by Product Type
        • 5.3.3.3 U.K.
          • 5.3.3.3.1 Market size and forecast, by Product Type
        • 5.3.3.4 Italy
          • 5.3.3.4.1 Market size and forecast, by Product Type
        • 5.3.3.5 Spain
          • 5.3.3.5.1 Market size and forecast, by Product Type
        • 5.3.3.6 Rest of Europe
          • 5.3.3.6.1 Market size and forecast, by Product Type
    • 5.4 Asia-Pacific

      • 5.4.1 Key trends and opportunities

      • 5.4.2 Asia-Pacific Market size and forecast, by Product Type

      • 5.4.3 Asia-Pacific Market size and forecast, by country

        • 5.4.3.1 Japan
          • 5.4.3.1.1 Market size and forecast, by Product Type
        • 5.4.3.2 China
          • 5.4.3.2.1 Market size and forecast, by Product Type
        • 5.4.3.3 India
          • 5.4.3.3.1 Market size and forecast, by Product Type
        • 5.4.3.4 Australia
          • 5.4.3.4.1 Market size and forecast, by Product Type
        • 5.4.3.5 South Korea
          • 5.4.3.5.1 Market size and forecast, by Product Type
        • 5.4.3.6 Rest of Asia-Pacific
          • 5.4.3.6.1 Market size and forecast, by Product Type
    • 5.5 LAMEA

      • 5.5.1 Key trends and opportunities

      • 5.5.2 LAMEA Market size and forecast, by Product Type

      • 5.5.3 LAMEA Market size and forecast, by country

        • 5.5.3.1 Brazil
          • 5.5.3.1.1 Market size and forecast, by Product Type
        • 5.5.3.2 Saudi Arabia
          • 5.5.3.2.1 Market size and forecast, by Product Type
        • 5.5.3.3 South Africa
          • 5.5.3.3.1 Market size and forecast, by Product Type
        • 5.5.3.4 Rest of LAMEA
          • 5.5.3.4.1 Market size and forecast, by Product Type
  • CHAPTER 6: COMPANY LANDSCAPE

    • 6.1. Introduction

    • 6.2. Top winning strategies

    • 6.3. Product Mapping of Top 10 Player

    • 6.4. Competitive Dashboard

    • 6.5. Competitive Heatmap

    • 6.6. Key developments

  • CHAPTER 7: COMPANY PROFILES

    • 7.1 Abbott Laboratories

      • 7.1.1 Company overview

      • 7.1.2 Company snapshot

      • 7.1.3 Operating business segments

      • 7.1.4 Product portfolio

      • 7.1.5 Business performance

      • 7.1.6 Key strategic moves and developments

    • 7.2 B. Braun Melsungen AG

      • 7.2.1 Company overview

      • 7.2.2 Company snapshot

      • 7.2.3 Operating business segments

      • 7.2.4 Product portfolio

      • 7.2.5 Business performance

      • 7.2.6 Key strategic moves and developments

    • 7.3 Becton, Dickinson and Company

      • 7.3.1 Company overview

      • 7.3.2 Company snapshot

      • 7.3.3 Operating business segments

      • 7.3.4 Product portfolio

      • 7.3.5 Business performance

      • 7.3.6 Key strategic moves and developments

    • 7.4 Boston Scientific Corporation

      • 7.4.1 Company overview

      • 7.4.2 Company snapshot

      • 7.4.3 Operating business segments

      • 7.4.4 Product portfolio

      • 7.4.5 Business performance

      • 7.4.6 Key strategic moves and developments

    • 7.5 Johnson and Johnson

      • 7.5.1 Company overview

      • 7.5.2 Company snapshot

      • 7.5.3 Operating business segments

      • 7.5.4 Product portfolio

      • 7.5.5 Business performance

      • 7.5.6 Key strategic moves and developments

    • 7.6 Medtronic Plc

      • 7.6.1 Company overview

      • 7.6.2 Company snapshot

      • 7.6.3 Operating business segments

      • 7.6.4 Product portfolio

      • 7.6.5 Business performance

      • 7.6.6 Key strategic moves and developments

    • 7.7 Edwards Lifesciences Corporation

      • 7.7.1 Company overview

      • 7.7.2 Company snapshot

      • 7.7.3 Operating business segments

      • 7.7.4 Product portfolio

      • 7.7.5 Business performance

      • 7.7.6 Key strategic moves and developments

    • 7.8 Teleflex Incorporated

      • 7.8.1 Company overview

      • 7.8.2 Company snapshot

      • 7.8.3 Operating business segments

      • 7.8.4 Product portfolio

      • 7.8.5 Business performance

      • 7.8.6 Key strategic moves and developments

    • 7.9 Cook Medical Inc.

      • 7.9.1 Company overview

      • 7.9.2 Company snapshot

      • 7.9.3 Operating business segments

      • 7.9.4 Product portfolio

      • 7.9.5 Business performance

      • 7.9.6 Key strategic moves and developments

    • 7.10 Stryker Corporation

      • 7.10.1 Company overview

      • 7.10.2 Company snapshot

      • 7.10.3 Operating business segments

      • 7.10.4 Product portfolio

      • 7.10.5 Business performance

      • 7.10.6 Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 2. CATHETERS MARKET REVENUE, FOR CARDIOVASCULAR CATHETERS, BY REGION , 2021-2031,($MILLION)
    TABLE 3. CATHETERS MARKET FOR CARDIOVASCULAR CATHETERS BY COUNTRY, 2021-2031,($MILLION)
    TABLE 4. CATHETERS MARKET REVENUE, FOR NEUROVASCULAR CATHETERS, BY REGION , 2021-2031,($MILLION)
    TABLE 5. CATHETERS MARKET FOR NEUROVASCULAR CATHETERS BY COUNTRY, 2021-2031,($MILLION)
    TABLE 6. CATHETERS MARKET REVENUE, FOR UROLOGICAL CATHETERS, BY REGION , 2021-2031,($MILLION)
    TABLE 7. CATHETERS MARKET FOR UROLOGICAL CATHETERS BY COUNTRY, 2021-2031,($MILLION)
    TABLE 8. CATHETERS MARKET REVENUE, FOR INTRAVENOUS CATHETERS, BY REGION , 2021-2031,($MILLION)
    TABLE 9. CATHETERS MARKET FOR INTRAVENOUS CATHETERS BY COUNTRY, 2021-2031,($MILLION)
    TABLE 10. CATHETERS MARKET REVENUE, FOR SPECIALTY CATHETERS, BY REGION , 2021-2031,($MILLION)
    TABLE 11. CATHETERS MARKET FOR SPECIALTY CATHETERS BY COUNTRY, 2021-2031,($MILLION)
    TABLE 12. CATHETERS MARKET, BY REGION, 2021-2031,($MILLION)
    TABLE 13. NORTH AMERICA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 14. NORTH AMERICA CATHETERS MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 15. U.S. CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 16. CANADA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 17. MEXICO CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 18. EUROPE CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 19. EUROPE CATHETERS MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 20. GERMANY CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 21. FRANCE CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 22. U.K. CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 23. ITALY CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 24. SPAIN CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 25. REST OF EUROPE CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 26. ASIA-PACIFIC CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 27. ASIA-PACIFIC CATHETERS MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 28. JAPAN CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 29. CHINA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 30. INDIA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 31. AUSTRALIA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 32. SOUTH KOREA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 33. REST OF ASIA-PACIFIC CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 34. LAMEA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 35. LAMEA CATHETERS MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 36. BRAZIL CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 37. SAUDI ARABIA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 38. SOUTH AFRICA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 39. REST OF LAMEA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
    TABLE 40.ABBOTT LABORATORIES: COMPANY SNAPSHOT
    TABLE 41.ABBOTT LABORATORIES: OPERATING SEGMENTS
    TABLE 42.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
    TABLE 43.ABBOTT LABORATORIES: NET SALES,
    TABLE 44.ABBOTT LABORATORIES: KEY STRATERGIES
    TABLE 45.B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
    TABLE 46.B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
    TABLE 47.B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
    TABLE 48.B. BRAUN MELSUNGEN AG: NET SALES,
    TABLE 49.B. BRAUN MELSUNGEN AG: KEY STRATERGIES
    TABLE 50.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
    TABLE 51.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
    TABLE 52.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
    TABLE 53.BECTON, DICKINSON AND COMPANY: NET SALES,
    TABLE 54.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
    TABLE 55.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
    TABLE 56.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
    TABLE 57.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
    TABLE 58.BOSTON SCIENTIFIC CORPORATION: NET SALES,
    TABLE 59.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
    TABLE 60.JOHNSON AND JOHNSON: COMPANY SNAPSHOT
    TABLE 61.JOHNSON AND JOHNSON: OPERATING SEGMENTS
    TABLE 62.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
    TABLE 63.JOHNSON AND JOHNSON: NET SALES,
    TABLE 64.JOHNSON AND JOHNSON: KEY STRATERGIES
    TABLE 65.MEDTRONIC PLC: COMPANY SNAPSHOT
    TABLE 66.MEDTRONIC PLC: OPERATING SEGMENTS
    TABLE 67.MEDTRONIC PLC: PRODUCT PORTFOLIO
    TABLE 68.MEDTRONIC PLC: NET SALES,
    TABLE 69.MEDTRONIC PLC: KEY STRATERGIES
    TABLE 70.EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
    TABLE 71.EDWARDS LIFESCIENCES CORPORATION: OPERATING SEGMENTS
    TABLE 72.EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
    TABLE 73.EDWARDS LIFESCIENCES CORPORATION: NET SALES,
    TABLE 74.EDWARDS LIFESCIENCES CORPORATION: KEY STRATERGIES
    TABLE 77.TELEFLEX INCORPORATED: PRODUCT PORTFOLIO
    TABLE 78.TELEFLEX INCORPORATED: NET SALES,
    TABLE 79.TELEFLEX INCORPORATED: KEY STRATERGIES
    TABLE 80.COOK MEDICAL INC.: COMPANY SNAPSHOT
    TABLE 81.COOK MEDICAL INC.: OPERATING SEGMENTS
    TABLE 82.COOK MEDICAL INC.: PRODUCT PORTFOLIO
    TABLE 83.COOK MEDICAL INC.: NET SALES,
    TABLE 84.COOK MEDICAL INC.: KEY STRATERGIES
    TABLE 75.TELEFLEX INCORPORATED: COMPANY SNAPSHOT
    TABLE 76.TELEFLEX INCORPORATED: OPERATING SEGMENTS
    TABLE 85.STRYKER CORPORATION: COMPANY SNAPSHOT
    TABLE 86.STRYKER CORPORATION: OPERATING SEGMENTS
    TABLE 87.STRYKER CORPORATION: PRODUCT PORTFOLIO
    TABLE 88.STRYKER CORPORATION: NET SALES,
    TABLE 89.STRYKER CORPORATION: KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 1.CATHETERS MARKET SEGMENTATION
    FIGURE 2.CATHETERS MARKET,2021-2031
    FIGURE 3.CATHETERS MARKET,2021-2031
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.CATHETERS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 12.CATHETERS MARKET,BY PRODUCT TYPE,2021(%)
    FIGURE 13.COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR CATHETERS CATHETERS MARKET,2021-2031(%)
    FIGURE 14.COMPARATIVE SHARE ANALYSIS OF NEUROVASCULAR CATHETERS CATHETERS MARKET,2021-2031(%)
    FIGURE 15.COMPARATIVE SHARE ANALYSIS OF UROLOGICAL CATHETERS CATHETERS MARKET,2021-2031(%)
    FIGURE 16.COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS CATHETERS CATHETERS MARKET,2021-2031(%)
    FIGURE 17.COMPARATIVE SHARE ANALYSIS OF SPECIALTY CATHETERS CATHETERS MARKET,2021-2031(%)
    FIGURE 18.CATHETERS MARKET BY REGION,2021
    FIGURE 19.U.S. CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 20.CANADA CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 21.MEXICO CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 22.GERMANY CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 23.FRANCE CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 24.U.K. CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 25.ITALY CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 26.SPAIN CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 27.REST OF EUROPE CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 28.JAPAN CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 29.CHINA CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 30.INDIA CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 31.AUSTRALIA CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 32.SOUTH KOREA CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 33.REST OF ASIA-PACIFIC CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 34.BRAZIL CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 35.SAUDI ARABIA CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 36.SOUTH AFRICA CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 37.REST OF LAMEA CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 38. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 39. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 40. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 41.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 42.COMPETITIVE DASHBOARD
    FIGURE 43.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 44.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
    FIGURE 45.B. BRAUN MELSUNGEN AG.: NET SALES ,($MILLION)
    FIGURE 46.BECTON, DICKINSON AND COMPANY.: NET SALES ,($MILLION)
    FIGURE 47.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
    FIGURE 48.JOHNSON AND JOHNSON.: NET SALES ,($MILLION)
    FIGURE 49.MEDTRONIC PLC.: NET SALES ,($MILLION)
    FIGURE 50.EDWARDS LIFESCIENCES CORPORATION.: NET SALES ,($MILLION)
    FIGURE 51.TELEFLEX INCORPORATED.: NET SALES ,($MILLION)
    FIGURE 52.COOK MEDICAL INC..: NET SALES ,($MILLION)
    FIGURE 53.STRYKER CORPORATION.: NET SALES ,($MILLION)

 
 

Rise in demand for minimally invasive surgeries for the diagnosis and treatment of cardiovascular, neurological, and other diseases drive the growth of the catheters market. Limited availability of plasma donors hinders the market growth. Further, catheter-based surgeries are minimally invasive and require shorter recovery times. Surgeries performed with the help of catheters are less invasive and led to faster recovery. 

Catheters help visualize and examine inaccessible parts of the body, further increasing the quality of treatment. The key players in catheters market launch products with higher flexibility, ease of use, and are made of materials resistant to growth of infectious organisms. Furthermore,  rise in prevalence of cardiovascular diseases and urinary tract infection(UTI) has increased the use of cardiovascular and urological catheters. The key players have increased their investment in R&D of catheters that help reduce the risk of catheter-associated infections due to the rise in number of people suffering from catheter-based infection,. In addition, increase in reimbursement rates for catheters increases the use of catheters for various therapeutic and diagnostic purposes.

The market gains interest of healthcare companies, owing to focus on preventive facilities provided to patients who are undergoing critical surgeries, which are more complex than other health conditions. This leads to increase in utilization of catheters, driving the growth of the market.

North America is expected to witness highest growth, in terms of revenue, owing to rise in geriatric population, presence of key players, and advancements in healthcare investments. Asia-Pacific was the second largest contributor to the market in 2021 and is expected to register fastest CAGR during the forecast period, owing to increase in number of urinary bladder cancer and kidney failure cases and unmet needs from advanced catheters. However, inadequate quality assurance and price competition at domestic levels are expected to hamper the market growth.
 

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. Catheter is a thin tube which is made from medical grade materials. They are medical devices that can be inserted in the body to treat diseases or perform a surgical procedure.

A. The total market value of catheters market is $22,659.21 million in 2021.

A. The forecast period for catheters market is 2022 to 2031

A. The market value of catheters market in 2031 is $49,469.93 million.

A. The base year is 2021 in catheters market

A. Top companies such as Abbott Laboratories, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Johnson & Johnson, Medtronic Inc. and Stryker Corporation held a high market position in 2021.

A. Cardiovascular catheter segment is the most influencing segment owing to rise in cardiovascular diseases that necessitate the use of catheters in diagnostic as well as surgical cardiac procedures.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Catheters Market

Start reading instantly.
This Report and over 66,944+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (May 2023 - May 2024)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2023 - May 2024)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2023 - May 2024)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2023 - May 2024)
  • Enterprise
    License/PDF

  • $10,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2023 - May 2024)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers